Janus Henderson Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Hold
89,000
﹤0.01% 2160
2025
Q4
$372K Buy
+89,000
New +$344K ﹤0.01% 2132
2023
Q2
Sell
-44,183
Closed -$46.6K 2649
2023
Q1
$46.6K Buy
44,183
+26,235
+146% +$37.8K ﹤0.01% 2668
2022
Q4
$27.2K Hold
17,948
﹤0.01% 2446
2022
Q3
$38K Hold
17,948
﹤0.01% 2143
2022
Q2
$24K Sell
17,948
-621
-3% -$921 ﹤0.01% 2584
2022
Q1
$39K Sell
18,569
-3
-0% -$7 ﹤0.01% 2626
2021
Q4
$69K Buy
+18,572
New +$79.9K ﹤0.01% 2524

Other funds holding PGEN

Janus Henderson Group's PGEN Position: Q1 2026 in Review

Janus Henderson Group held its Precigen (PGEN) position steady in Q1 2026 at 89,000 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Janus Henderson Group first reported a position in PGEN in Q4 2021 and has held it in 8 quarters since. The position peaked at $372K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Janus Henderson Group held 89,000 shares of Precigen worth $344K as of Q1 2026.
  • Janus Henderson Group left its Precigen share count unchanged in Q1 2026.
  • Precigen made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2160 holding.
  • Janus Henderson Group first reported a position in Precigen in Q4 2021 and has held it in 8 quarters since.
  • Janus Henderson Group's Precigen position peaked at $372K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.